Rani Therapeutics Holdings Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -52.8% | +488.1% | -100.0% | – | – | +58.9% | |
| – | – | – | – | -37.3% | – | – | |
| – | -52.8% | +488.1% | -148.3% | – | – | -28.7% | |
| – | -51.0% | +119.9% | +38.2% | +8.2% | -32.7% | -24.3% | |
| – | +43.2% | +460.9% | -3.6% | -1.4% | -9.6% | -17.6% | |
| – | -39.4% | +219.4% | +16.8% | +2.9% | -16.8% | -28.2% | |
| – | – | – | – | – | – | – | |
| – | +1,140.0% | +275.8% | +129.8% | +374.8% | -1.0% | -42.6% | |
| – | – | – | – | – | – | – | |
| – | +250.0% | +17.1% | +70.7% | -48,547.1% | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.